Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Anamorelin hydrochloride by Helsinn Healthcare for Obesity: Likelihood of Approval
Anamorelin hydrochloride is under clinical development by Helsinn Healthcare and currently in Phase II for Obesity. According to GlobalData, Phase...